UK raps Pfizer over inflated epilepsy drug prices | Fin24
 
  • Covid-19 Money Hub

    The hub will help answer your business and money questions during the coronavirus crisis.

  • Cigarettes

    The tobacco ban is a 'deal with the devil' that undermines transformation, say lobby groups.

  • Easing the Lockdown

    Liquor makers want bars to become drink-collection points when the alcohol ban lifts.

Loading...

UK raps Pfizer over inflated epilepsy drug prices

Aug 06 2015 10:30

London - Britain's competition watchdog alleged on Thursday that US drug maker Pfizer and Flynn Pharma had breached competition law by ramping up the cost of an epilepsy drug used by more than 50 000 British patients.

The Competition and Markets Authority (CMA) said its provisional view was that Pfizer and Flynn Pharma each abused a dominant position by charging "excessive and unfair" prices for phenytoin sodium capsules.

Officials at Pfizer were not immediately available to comment.

Pfizer, which was in politicians' crosshairs last year after trying to buy British rival AstraZeneca, manufactures the drug and Flynn distributes it.

The US group used to market the medicine itself, under the brand name Epanutin, but sold the rights to Flynn in September 2012, since when the price at which the product is sold to Flynn has surged, the CMA said.

"Flynn then sold the drug on to customers at prices which were between 25 and 27 times higher than those historically charged by Pfizer," the CMA said in a statement.

As a result, the state-run National Health Service, which used to spend around £2.3m on phenytoin sodium capsules annually, saw its bill jump to more than 50 million in 2013 and more than 40 million in 2014.

pfizer  |  competition  |  health
NEXT ON FIN24X

 
 
 

Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Comments have been closed for this article.
 

Company Snapshot

Voting Booth

How has Covid-19 impacted your financial position?

Previous results · Suggest a vote

Loading...